The Eindhoven startup Salvia BioElectronics B.V. has received additional investment from the Brabant Startup Fund (BSF), bringing the total seed funding to €3.1 million. The startup already received investment from the Brabant Development Agency (BOM) and Thuja Capital, which is complemented with a loan from the Netherlands Enterprise Agency (RVO). At the High Tech Campus Eindhoven, Salvia develops a minimally invasive bioelectronics solution for people suffering from chronic neurological disease.
Hubert Martens, CEO of Salvia BioElectronics, noted: “We are very pleased to attract this additional funding that allows us to further mature our technology before initiating the product development phase. This will translate in a substantial acceleration of the product development phase after the upcoming series-A funding round.” Gerard Spanbroek, director of the Brabant Startup Funded added: “The BSF supports early-stage innovative companies with a strong growth potential. We are keen on supporting Salvia towards their next growth phase. We are impressed by the progress that this experienced team realized in a short amount of time and see significant potential health benefits of their novel product concept.”
Innovation Origins is an independent news platform, which has an unconventional revenue model. We are sponsored by companies that support our mission: spreading the story of innovation. Read more here.
On Innovation Origins you can always read articles for free. We want to keep it that way. Have you enjoyed this article so much that you want to contribute to independent journalism? Click here: